Education
About Us
Working with TipRanks
Follow Us
VEA - ETF AI Analysis
Top Page
Vanguard FTSE Developed Markets ETF (VEA)
Rating:60Neutral
Price Target:―
Positive Factors
Low Expense Ratio
The ETF charges a very low expense ratio, making it cost-effective for investors.
Global Diversification
The fund has exposure to multiple countries, including Japan, the UK, and France, reducing reliance on any single market.
Strong Holdings Performance
Several top holdings, such as ASML Holding NV and Nestlé SA, have delivered strong year-to-date gains, supporting the fund’s overall performance.
Negative Factors
Underperforming Holdings
Some key holdings, like SAP SE and Toyota Motor, have lagged in performance, which could weigh on returns.
Sector Concentration in Financials
The fund has significant exposure to the financial sector, which may increase sensitivity to economic downturns.
Limited U.S. Exposure
The ETF has relatively low exposure to U.S. companies, which may limit participation in the strong performance of the U.S. market.
VEA vs. SPDR S&P 500 ETF (SPY)
AUM190.41B
RegionDeveloped Markets
Expense Ratio0.03%
Beta0.73
IssuerVanguard
Inception DateJul 20, 2007
Dividend Yield2.69%
Asset ClassEquity
Index TrackedFTSE Developed ex US All Cap Net Tax (US RIC) Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume14,545,272
30 Day Avg. Volume12,996,030
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
72.87Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering3318
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
VEA Summary
The Vanguard FTSE Developed Markets ETF (Ticker: VEA) is an investment fund that focuses on stocks from developed countries outside of North America, such as Japan, the UK, and Australia. It includes companies from various sectors like finance, technology, and healthcare, with well-known names like Toyota and Nestlé among its top holdings. This ETF follows the FTSE Developed All Cap ex US Index, offering a simple way to diversify your portfolio internationally and benefit from the growth of stable, established economies. However, new investors should know that its performance can be affected by global economic conditions, which may cause the value of the ETF to rise or fall.
How much will it cost me?The Vanguard FTSE Developed Markets ETF (VEA) has an expense ratio of 0.03%, meaning you’ll pay $0.30 per year for every $1,000 invested. This is much lower than average because it’s a passively managed fund that tracks an index, keeping costs minimal.
What would affect this ETF?The Vanguard FTSE Developed Markets ETF (VEA) could benefit from economic growth in developed markets outside North America, particularly if sectors like financials, technology, and healthcare continue to perform well. However, challenges such as rising interest rates, geopolitical tensions, or regulatory changes in key regions like Europe and Asia could negatively impact its holdings and overall performance.
VEA Top 10 Holdings
The Vanguard FTSE Developed Markets ETF (VEA) leans heavily on European and Asian giants, with a notable presence in financials and industrials. HSBC and Roche are rising stars, buoyed by strong earnings and strategic initiatives, while AstraZeneca adds steady healthcare strength. On the flip side, SAP and Siemens are lagging, with bearish momentum and mixed signals holding back performance. Nestlé and Novartis offer stability but lack the spark to drive the fund forward. Overall, the ETF’s global diversification provides balance, though its reliance on developed-market stalwarts means growth may be steady rather than explosive.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 1.50% | $3.89B | €353.45B | 34.96% | 76 Outperform | |
| SAP SE | 0.96% | $2.50B | €242.99B | -13.49% | 66 Neutral | |
| AstraZeneca | 0.89% | $2.31B | £208.42B | 28.43% | 80 Outperform | |
| HSBC Holdings | 0.88% | $2.28B | HK$1.99T | 45.10% | 80 Outperform | |
| Nestlé SA | 0.87% | $2.26B | CHF197.01B | 16.44% | 71 Outperform | |
| Novartis AG | 0.83% | $2.16B | CHF200.79B | 20.24% | 80 Outperform | |
| Roche Holding AG | 0.82% | $2.12B | CHF253.28B | 42.40% | 73 Outperform | |
| Shell (UK) | 0.79% | $2.06B | £153.44B | 7.52% | 73 Outperform | |
| Toyota Motor | 0.78% | $2.03B | ¥42.49T | 20.85% | 80 Outperform | |
| Siemens | 0.75% | $1.95B | €185.66B | 22.73% | 74 Outperform |
VEA Technical Analysis
Positive
―
Price Trends
61.00
Positive
59.77
Positive
56.46
Positive
Market Momentum
0.48
Negative
61.70
Neutral
86.51
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For VEA, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 61.19, equal to the 50-day MA of 61.00, and equal to the 200-day MA of 56.46, indicating a bullish trend. The MACD of 0.48 indicates Negative momentum. The RSI at 61.70 is Neutral, neither overbought nor oversold. The STOCH value of 86.51 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for VEA.
VEA Peer Comparison
Comparison Results
Performance Comparison
VEA
Vanguard FTSE Developed Markets ETF
62.48
14.29
29.65%
SCHF
Schwab International Equity ETF
―
―
―
SPDW
SPDR Portfolio Developed World ex-US ETF
―
―
―
IDEV
iShares Core MSCI International Developed Markets ETF
―
―
―
IQLT
iShares MSCI Intl Quality Factor ETF
―
―
―
DFAI
Dimensional International Core Equity Market ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents